Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Ultomiris (ravulizumab-cwvz) dosage, administration, and important patient information for conditions like PNH, aHUS, gMG, and NMOSD. Understand infusion times, schedules, and what to do if you miss a dose.
Ultomiris, with the active ingredient ravulizumab-cwvz, is a crucial medication prescribed for specific inflammatory conditions. It belongs to a class of drugs known as complement inhibitors, which play a vital role in regulating the immune system. This blog post aims to provide a comprehensive overview of Ultomiris, focusing on its dosage, how it is administered, and essential information for patients in India. We will cover its uses, forms, strengths, dosing schedules for various conditions, and what to do if you miss a dose.
Ultomiris is a prescription medication used to treat several serious conditions, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). These conditions often involve an overactive immune response that can damage the body's own cells. Ultomiris works by inhibiting a part of the immune system called the complement system, which helps to reduce this harmful immune activity and protect the body.
Ultomiris is available as a liquid solution intended for intravenous (IV) infusion. This means it is administered directly into a vein over a period of time by a qualified healthcare professional in a clinical setting, such as a doctor's office or hospital. The medication comes in a single strength of 100 mg/mL, available in two vial sizes: 3 milliliters (mL) and 10 mL.
The administration of Ultomiris is always performed by a healthcare provider. The duration of the infusion can vary depending on the prescribed dose, typically ranging from 24 minutes to 90 minutes or even longer. Your doctor will determine the appropriate infusion time based on your individual needs and the specific dosage you receive.
The dosage of Ultomiris is carefully determined based on your body weight in kilograms (kg). Your doctor will regularly monitor your weight to ensure you receive the correct dose. The treatment typically begins with a higher initial dose, known as a loading dose, to quickly establish therapeutic levels of the medication. This is followed by regular maintenance doses to sustain the drug's effect.
For adults and children aged 1 month and older diagnosed with PNH or aHUS, the dosing schedule is as follows:
It's important to note that the dosage for aHUS is the same as for PNH.
For adults with gMG, the dosing schedule is slightly different:
Ultomiris is approved for treating gMG in certain adults. It is not approved for treating gMG in children.
For adults with NMOSD, the dosing schedule follows a similar pattern to gMG, with a loading dose followed by maintenance doses administered every 8 weeks. Ultomiris is approved for treating NMOSD in certain adults. It is not approved for treating NMOSD in children.
If you miss an appointment for your Ultomiris IV infusion, it is crucial to contact your doctor's office immediately. The goal is to receive the missed infusion within 7 days of its originally scheduled date. Once you receive the missed dose, you will resume your original dosing schedule for subsequent treatments.
Plasma Exchange, Plasmapheresis, or Intravenous Immunoglobulin (IVIg): If you undergo treatments such as plasma exchange, plasmapheresis, or receive IVIg, your Ultomiris dosage may need to be adjusted. These procedures can reduce the levels of Ultomiris in your body, and your doctor will determine if a supplemental dose is necessary to maintain adequate drug levels.
It is essential to discuss any concerns or questions you have about Ultomiris with your healthcare provider. They can provide personalized information regarding your treatment plan, dosage adjustments, and potential side effects. Always follow their guidance closely.
The active ingredient in Ultomiris is ravulizumab-cwvz.
No, Ultomiris is administered intravenously (IV) by a healthcare professional and cannot be taken orally.
The infusion time can vary from 24 minutes to 90 minutes or longer, depending on the dose prescribed by your doctor.
Ultomiris is approved for treating PNH and aHUS in children aged 1 month and older. It is not approved for gMG or NMOSD in children.
Contact your doctor's office immediately. You should aim to receive the missed infusion within 7 days of the scheduled date, and then continue with your regular schedule.
Disclaimer: This information is intended for educational purposes and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026